Establishment of the Abu Dhabi Emirate Thalassemia Longitudinal Cohort (AD-TLC): leveraging the power of observation
Ann Hematol
.
2023 Aug;102(8):2277-2278.
doi: 10.1007/s00277-023-05252-z.
Epub 2023 May 10.
Authors
Khaled M Musallam
1
,
Wesam Ahmed
2
,
Mozah Obaid Almarshoodi
3
,
Omar Trad
4
,
Naser Al Zein
5
,
Shamyla Siddique
6
,
Nastaran Shekary
7
,
Sulaima Daboul
7
,
Shahrukh Hashmi
7
8
9
Affiliations
1
Thalassemia Center, Burjeel Medical City, 28th Street, Mohammad Bin Zayed City, PO Box 92510, Abu Dhabi, United Arab Emirates.
[email protected]
.
2
Division of Hematology and Medical Oncology, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
3
Hematology Clinics, Tawam Hospital, Al-Ain, United Arab Emirates.
4
Division of Pediatric Hematology and Oncology, Tawam Hospital, Al-Ain, United Arab Emirates.
5
Division of Pediatric Hematology and Oncology, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates.
6
Thalassemia Center, Burjeel Medical City, 28th Street, Mohammad Bin Zayed City, PO Box 92510, Abu Dhabi, United Arab Emirates.
7
Department of Medicine, Sheikh Shakhbout Medical City, Abu Dhabi, United Arab Emirates.
8
Department of Medicine, Mayo Clinic, Rochester, MN, USA.
9
College of Medicine and Health Sciences, Khalifa University, Abu Dhabi, UAE.
PMID:
37162516
DOI:
10.1007/s00277-023-05252-z
No abstract available
Publication types
Letter
MeSH terms
Cohort Studies
Humans
Longitudinal Studies
Thalassemia*
United Arab Emirates / epidemiology